CHACMPEP Trademark

Trademark Overview

On Tuesday, July 2, 2024, a trademark application was filed for CHACMPEP with the United States Patent and Trademark Office. The USPTO has given the CHACMPEP trademark a serial number of 98630309. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by RJK Biopharma Inc.. The CHACMPEP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Quality control for others; Mechanical research; Technical consultancy in relation to research services relating to foods and dietary supplements; Scientific research; Scientific laboratory services; Medical and scientific research, namely, conducting clinical trials for others; Bacteriological research; Biological research; Material testing; Industrial design; Consultancy in the design and development of computer hardware; Computer software design services; Cloud computing featuring software for use in neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration treatment; All the above-mentioned services relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration
chacmpep

General Information

Serial Number98630309
Word MarkCHACMPEP
Filing DateTuesday, July 2, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements

Pseudo MarkCHACM PEP
Goods and ServicesQuality control for others; Mechanical research; Technical consultancy in relation to research services relating to foods and dietary supplements; Scientific research; Scientific laboratory services; Medical and scientific research, namely, conducting clinical trials for others; Bacteriological research; Biological research; Material testing; Industrial design; Consultancy in the design and development of computer hardware; Computer software design services; Cloud computing featuring software for use in neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration treatment; All the above-mentioned services relating to neurodegenerative diseases, Amyotrophic Lateral Sclerosis, Parkinson's Disease, Alzheimer's Disease, Cataract, dry Age-related Macular Degeneration

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRJK Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSHANGHAI 201315
CN
Party NameRJK Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSHANGHAI 201315
CN

Trademark Events

Event DateEvent Description
Tuesday, July 2, 2024NEW APPLICATION ENTERED
Tuesday, January 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 21, 2025ASSIGNED TO EXAMINER
Sunday, February 9, 2025NON-FINAL ACTION WRITTEN
Sunday, February 9, 2025NON-FINAL ACTION E-MAILED
Sunday, February 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 21, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 26, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

chacmpep research disease services design scientific lateral sclerosis others amyotrophic diseases